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OTITIS EXTERNA
Infection of the external auditory canal (EAC) is common and in
certain circumstances can be life threatening. The EAC has high-
ly effective mechanisms to prevent infection, which include migra-
tion of the skin covering the tympanic membrane and deep exter-
nal canal, and the production of wax that has antibacterial and
antifungal properties.  Infection (otitis externa) will usually arise
when these defences are overcome.  Symptoms of otitis externa
include otalgia, pruritus, discharge and hearing loss. The patient
may experience pain with tragal pressure, or when the auricle is
pulled upwards. The skin lining the ear canal is usually swollen
and inflamed, and may be lined with debris.  An approach to
diagnosis and management of otitis externa is shown in Table I. 
Patients with non-infective otitis externa present with itch of
the ear canal and they are usually in the 40 - 50-year age
group.  On examination the ear canal is absolutely normal and
there is absence of wax.  The treatment of choice is application
of combination steroid/antifungal/antibiotic ointment (e.g.
Kenacomb) with a cotton bud daily for 3 days.
Patients with fungal otitis externa present with ‘blockage’ of
the ear.  On examination white debris similar to the cream of
milk with black or white fungal spores is noted in the external
ear canal.  Treatment is to remove the debris by either syringing
or suction and then packing the ear canal with 10 mm wide and
75 mm long ribbon gauze impregnated with combination
steroid/antifungal/
antibiotic ointment (e.g Kenacomb) for 48 hours.  The treatment
is repeated until the patient is asymptomatic. Fungal and bacteri-
al infections commonly occur together.
The patients with bacterial otitis externa are usually young
adults who present with severe otalgia and fever after swimming
in infected waters such as dams, rivers or the sea.  On examina-
tion there is marked oedema of the ear canal with complete
occlusion of the lumen.  The treatment includes packing the ear
canal with 10 mm wide and 75 mm long ribbon gauze impreg-
nated with ichthammol glycerin, antibiotics and analgesics. The
ear pack must be changed every 24 hours until the oedema sub-
sides completely.
Necrotising otitis externa with skull base
osteitis
This is a condition peculiar to elderly diabetic patients living in
hot humid regions.  The disease commences as osteitis of the
B SINGH 





Head and Neck Surgery
Nelson R Mandela School
of Medicine 
University of Natal 
Durban
Bharath Singh received the
MB ChB and MMed
degrees from the 
University of Natal in 1981
and 1988, respectively. His
areas of special interest
are head and neck surgery. 
COMMON INFECTIONS OF THE
EAR
Ear infections, both of the inner and outer ear, are common in general practice.
tympanic plate of the temporal bone
and then spreads posteriorly to involve
the tympanomastoid bone and medial-
ly along the base of the petrous bone
towards the foramen magnum. 
The exact aetiology is unknown but
Pseudomonas aeruginosa has been
persistently isolated from pus swab.
Pseudomonas has the propensity to
attach itself to diseased blood vessels
leading to thrombosis, which explains
the necrosis of soft tissue and bone in
diabetic patients who already have
microangiopathy.
Four stages of the disease are recog-
nised:
• Stage 1 — Osteitis of the tympanic
plate of temporal bone only. The
patient presents with deep-seated,
agonising and unrelenting earache
which is worst at night. The sign
that heralds osteitis of the tympanic
plate is granulation tissue on the
floor of the ear canal at the junc-
tion of the tympanic plate and the
cartilaginous portion of the ear
canal.
• Stage 2 — Osteitis of tympanic
plate and stylomastoid bone. The
patient presents with lower motor
neuron VII cranial nerve palsy.
• Stage 3 — Osteitis of the base of
the petrous bone with involvement
of the jugular foramen and
hypoglossal canal. The patient
presents with IX, X, XI and XII cra-
nial nerve palsies.
• Stage 4 — Intracranial extension.
Diagnosis
The diagnosis is clinical and the gold-
en rule applies: Any diabetic patient
who presents with deep-seated agonis-
ing earache has skull base osteitis
until proven otherwise. The investiga-
tion of choice is technetium99 bone
scan.
Treatment
The treatment of choice is intravenous
antibiotics consisting of aminoglyco-
side, piperacillin and metronidazole
for a minimum period of 6 weeks.  In
those patients with impaired renal
function, the recommended treatment
is intravenous ciprofloxacin and
metronidazole.   
Response to treatment is monitored by
performing serial technetium bone
scans at 3-weekly intervals.
Antibiotics are only stopped when the
bone scan is negative.
Prognosis
Prognosis is dependent on the stage of
the disease.  With stage 1 disease the
prognosis is excellent; complete recov-
ery occurs in all patients. The progno-
sis is poor in advanced disease. 
ACUTE OTITIS MEDIA
Acute otitis media is inflammation of
the mucoperiosteal lining of the middle
ear cleft, i.e. the Eustachian tube, tym-
panic cavity, attic, mastoid antrum,
and mastoid air cells. When inflamma-
tion affects the bony wall or spreads
beyond the walls into the adjacent
area, it is referred to as a complica-
tion of otitis media, e.g. otitis media
with meningitis or otitis media with
facial palsy.
Otitis media is common in children,
with peak incidence in the 1 - 2-year
age group, and usually follows upper
respiratory tract infection.  The infec-
tion spreads to the middle ear via the
Eustachian tube.   
Four stages of acute otitis media are
recognised:
• Stage 1 — Stage of tubal occlusion
is characterised by negative middle
ear pressure with an effusion. Adult
patients complain of a blocked ear
and autophonia (echoing of one’s
own voice). The ear drum is retract-
ed and the light reflex may be
absent. There may be clinical evi-
dence of middle ear effusion, for
example air bubbles and fluid in
the middle ear space.1
• Stage 2 — Stage of presuppura-
tion. The middle ear effusion
becomes infected and increases in
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Table I. Approach to otitis externa
Type Associated Characteristic features Precipitating Treatment
symptom in external ear canal factors
Non-infective Itch Normal Nil Acetic acid drops/steroid drops 
if severe
Fungal Hearing loss White debris with fungal Nil Acetic acid drops/combination 
spores steroid/anti-fungal/antibiotic  
(e.g. Kenacomb) ear pack if 
severe
Bacterial Severe pain Oedema with occlusion Swimming Ichthammol glycerin, combination
of the EAC steroid/antifungal/antibiotic (e.g.
Kenacomb), intravenous 
co-amoxiclav if severe
Necrotising Deep-seated Granulation tissue at  Diabetes Intravenous antibiotics (see text)
earache junction of bony and
cartilaginous EAC
quantity and the patients have a
fever and complain of throbbing
earache. Children often vomit. The
tympanic membrane is inflamed
and bulges outwards.1
• Stage 3 — Stage of suppuration.
The intratympanic pressure increas-
es and occludes the blood supply
resulting in necrosis and rupture of
the tympanic membrane. This event
is characterised by the patients
reporting excruciating pain fol-
lowed by a ‘pop’ and discharge,
with immediate relief of earache.
On examination a central perfora-
tion of the tympanic membrane is
noted with pus oozing from the
middle ear into the external ear
canal.1
• Stage 4 — Stage of resolution. In
80% of patients complete resolution
occurs: the otorrhoea subsides and
the perforation heals spontaneously
after a week. In 20% of patients,
incomplete resolution occurs: the
perforation and otorrhoea persist
or the perforation heals with middle
ear effusion.1
Acute otitis media is the most common
reason for antibiotic prescription in
children.   Accurate identification of
the causative pathogen can only be
made by performing tympanocentesis
— an invasive procedure that is
almost never performed by clinicians.
Therapy is therefore empiric, based on
clinical studies identifying causative
organisms, and on knowledge of
antibiotic susceptibility patterns of the




Moraxella catarrhalis (see Table II).
Otitis media caused by pneumococcus
is least likely to resolve spontaneously,
and it is important that first-line empir-
ic antibiotics treat pneumococcal infec-
tion adequately.  There has been a
worldwide increase in drug-resistant
Streptococcus pneumoniae (DRSP),
and empiric therapy needs to take this
into account.   Of importance, resist-
ance is due to a change in the affinity
of penicillin-binding proteins in the
bacterial cell wall and not to beta-lac-
tamase production, as is the case with
resistant H. influenzae. Thus DRSP
has increased resistance to all beta-
lactam antibiotics, including the
cephalosporins.2
Table III gives the minimum inhibitory
concentration required to treat DRSP
for a selection of beta-lactam antibi-
otics that are commonly prescribed for
the treatment of respiratory tract infec-
tions.  The table includes the antibiotic
level that is reached at the site of
action — the middle ear fluid.  Of
importance, cefpodoxime, cefaclor
and loracarbef are ineffective agents
for treatment of DRSP.  Amoxicillin
remains the drug of choice when treat-
ing otitis media due to DRSP, and lev-
els adequate for the treatment of DRSP
may be attained by using higher
doses.  Ceftriaxone is an excellent
agent, but must be given parenterally,
and is therefore most useful in treating
the younger child with otitis media
who is very unwell and cannot tolerate
oral medication.2
Benefits of antibiotic
treatment for otitis media
A Cochrane review of antibiotics for
acute otitis media in children showed
no reduction in pain at 24 hours in
children treated with antibiotics, com-
pared with those treated with placebo.
By 24 hours, two-thirds of children
had recovered spontaneously, whether
or not they were treated with antibi-
otics. Overall, antibiotics showed only
modest benefit over placebo in pain
reduction. Seven per cent fewer chil-
dren had pain after 2 - 7 days, which
means that 15 children needed to be
treated with antibiotics to prevent 1
child from experiencing pain after 
2 - 7 days.2
Because many cases of otitis media
will resolve spontaneously, benefits of
antibiotic therapy must be weighed up
against the risk of adverse reactions to
antibiotic therapy. In an older child
who is otherwise well, a delay in initi-
ating antibiotics may be considered.
Antibiotics may, however, play an
important role in reducing the risk of
complications of otitis media, particu-
larly mastoiditis.
Recommended first-line
treatment for otitis media
An assessment of the risk of infection
with DRSP must be made. Risk factors
for infection due to resistant
Streptococcus pneumoniae are as fol-
lows:
• age less than 2 years
• antibiotic treatment in the last 1 - 3
months
• attendance at a day care centre.
A child who is at high risk of DRSP
infection should be treated empirically
with high-dose amoxicillin (80 - 90
mg/kg/day of amoxicillin, in 3 divid-
ed doses).  Those with a low risk of
infection with DRSP may be treated
with amoxicillin 40 - 45 mg/kg/day.
Management of clinically
defined treatment failure
Treatment failure is a lack of clinical
improvement after 3 days of therapy,
with persistence of ear pain, fever,
and redness and bulging of the tym-
panic membrane, or ottorrhoea.
Treatment may fail due to lack of com-
pliance, due to infection with DRSP
which has been inadequately treated,
or due to inappropriate choice of
antibiotic (see Table III), or too low a
dose of amoxicillin.  Treatment with
amoxicillin may also fail in cases
where the causative organism is resist-
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Other streptococci 5 - 10%
Staphylococci 5%
No organism isolated 10 - 20%
ant due to beta-lactamase production
(e.g. beta-lactamase-producing H.
influenzae).2
Suitable antibiotics for management of
treatment failure include high-dose
amoxicillin-clavulanate (80 - 90 mg/
kg/day of the amoxicillin component,
with 6.4 mg/kg/day of clavulanate)
or intramuscular ceftriaxone 50 mg/
kg/day for 3 days.
CHRONIC OTITIS MEDIA
Chronic otitis media is osteitis of the
mastoid bone and is characterised by
persistent otorrhoea and tympanic
membrane perforation. Two types are
recognised — non-cholesteatomatous
and cholesteatomatous chronic otitis
media. The former is usually associat-
ed with central perforation and the lat-
ter with posterior superior marginal
perforation. It is important to make the
distinction at the initial visit, so that
appropriate treatment can be instituted
immediately. 
Cholesteatoma
Cholesteatoma is accumulated desqua-
mated squamous epithelium in the mid-
dle ear cleft.  Under normal circum-
stances squamous epithelium is present
only in the outer layer of the tympanic
membrane and the skin of the external
ear canal.  No squamous epithelium is 
present in the middle ear cleft.
The underlying pathophysiology in 
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Table IV. Complications of otitis media
Extracranial complications Presentation
Post-auricular abscess Post-auricular swelling
Facial palsy Drooling of saliva from angle of mouth and inability to close 
the ipsilateral eye on the same side
Labyrinthitis Dizziness with nausea and vomiting
Bezold’s abscess Swelling of the mastoid tip
Petrous apicitis Ipsilateral otorrhoea, VI cranial nerve palsy, and facial pain
Intracranial complications
Extradural empyema ‘Silent’ or nuchal rigidity and pyrexia
Subdural empyema Headache, pyrexia, with or without hemiparesis
Brain abscess:
• Temporal lobe Nuchal rigidity, aphasia, hemiparesis
• Cerebellar Dizziness and unstable gait
• Lateral sinus thrombosis Headache, pyrexia, and rigors, pain over the anterior 
border of sternocleidomastoid muscle
Meningitis Severe headache, pyrexia, neck stiffness
Otitic hydrocephalus Headache, nausea, and vomiting
Table III. Activity of a selection of beta-lactam drugs, at standard doses, against DRSP2
Beta-lactam MIC90 (µg/ml) MIC90 (µg/ml) MIC90 (µg/ml) Peak serum Peak middle ear 
antibiotic Penicillin- Penicillin- Penicillin- concentration fluid concentration 
susceptible intermediate resistant (µg/ml) (µg/ml)
strain strain strain
Amoxicillin 0.03 0.1 - 1 2 - 4 3.5 - 7 1 - 6
Ceftriaxone 0.06 1 1 - 4 171 35
(e.g. Rocephin)
Cefuroxime 0.125 1 - 4 4 2 - 7 1
(e.g. Zinnat)
Cefpodoxime 0.06 1 - 4 4 1 - 4 0.2
(e.g. Orelox)
Cefaclor 1 64 128 7 - 13 0.5 - 4
(e.g. Ceclor)
Loracarbef 2 64 128 13 - 19 2
(e.g. Lorabid)
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Infection of the external
auditory canal (EAC) is
common and in certain cir-
cumstances can be life-
threatening.
Patients with bacterial otitis
externa are usually young
adults who present with
severe otalgia and fever
after swimming in infected
waters such as dams, rivers
or the sea.
Any diabetic patient who
presents with deep-seated
agonising earache has
skull base osteitis until
proven otherwise. 
Because many cases of oti-
tis media will resolve spon-
taneously, benefits of
antibiotic therapy must be
weighed up against the
risk of adverse reactions to
antibiotic therapy. 
cholesteatoma formation is Eustachian
tube dysfunction.
With occlusion of the Eustachian tube
a negative pressure is created within
the middle ear cleft, resulting in medi-
al retraction of the superior posterior
part of the tympanic membrane (pars
flaccida) into the epitympanum (attic).
The squamous epithelium in the retrac-
tion pocket continuously desquamates
and if successful outward migration
does not occur, the squamous epitheli-
um accumulates in the pocket and this
is referred to as cholesteatoma. As
more desquamated squamous epitheli-
um accumulates, the retraction pocket
gets larger and extends into the mas-
toid antrum. Cholesteatoma is consid-
ered a serious condition because it
promotes the growth of bacteria and
releases proteolytic enzymes, which
cause bone resorption. Both these fac-
tors are responsible for the spread of
the infection within and outside the
temporal bone, resulting in complica-
tions associated with chronic otitis
media.
The diagnosis of cholesteatoma is clin-
ical, the presence of whitish, cheese-
like material is diagnostic. The most
common site is the attic and a polyp
in the ear canal often heralds the pres-
ence of cholesteatoma.
The treatment of choice for
cholesteatoma is complete surgical
excision of the cholesteatomatous sac
by a modified radical mastoidectomy.
There is no place for conservative
treatment. 
Management of a non-
cholesteatomatous
discharging ear
The treatment aim is to dry the ear so
that spontaneous healing of the tym-
panic membrane can take place.
There are four sequential steps to
achieve a dry ear:
• Step 1. Antibiotics, aural toilet, and
application of eardrops. The 10-
day antibiotic treatment consists of
amoxicillin, co-amoxiclav or
cefuroxime. Aural toilet must be
performed twice daily with cotton
wool and sticks (commercially man-
ufactured cotton wool buds are not
recommended).  Immediately after
dry mopping, ear drops containing
0.5% phenol must be applied. This
treatment must be continued for 1
month. Patients in whom this treat-
ment fails are moved to the next
step.
• Step 2. Remove possible predispos-
ing factors.  Tonsillectomy, ade-
noidectomy and bilateral antral
wash-out must be performed.
Radiograph of the paranasal sinus-
es and lateral neck may be request-
ed to confirm or exclude sinusitis
and/or enlarged adenoid glands.
Remember that radiological
absence of adenoid gland hyper-
trophy does not exclude chronic
adenoiditis. After removal of pre-
disposing factors, continue with
aural toilet and application of
eardrops for 1 month. If otorrhoea
fails to subside, then move to the
next step.
• Step 3. Intravenous antibiotic thera-
py. A pus swab is taken and ampi-
cillin (50 mg/kg/d) with metronida-
zole (20 mg/kg/d) are adminis-
tered intravenously for 48 hours.
The response is reviewed. If the
otorrhoea is subsiding, then contin-
ue with the treatment another 8
days. If the otorrhoea remains
unchanged check the culture and
sensitivity results of the pus swab
and prescribe appropriate antibi-
otics and continue treatment for 10
days. Patients in whom otorrhoea
fails to subside are moved to the
next step.  
The success rate of drying the ear
with conservative treatment (steps
1, 2, and 3) is 90%.
• Step 4.  Mastoidectomy is the sur-
gical procedure for eradicating dis-
ease from the mastoid bone. It
involves exenterating all the dis-
eased mastoid bone with a micro-
surgical drill and removing infected
granulation tissue from the middle
ear, attic and mastoid cavities.
Simple or cortical mastoidectomy is
recommended for the non-choles-
teatomatous ear.
Mastoidectomy is a surgical proce-
dure to eradicate disease from the
middle ear cleft and basically two
types are recognised — cortical  and
modified radical mastoidectomy.  
Cortical mastoidectomy is indicated
for non-cholesteatomatous chronic oti-
tis media and modified radical mas-
toidectomy for cholesteatomatous
chronic otitis media.
The anatomical difference between the
two is that in the modified radical
mastoidectomy the bony partition
between the external ear canal and
the mastoid cavity is excised complete-
ly while in the cortical mastoidectomy
it is retained. The functional difference
between the two procedures is that the
modified radical mastoidectomy is
associated with approximately 60
decibel hearing loss.
Mastoidectomy can be performed at
any age depending on the indication.
Tympanoplasty is a surgical proce-
dure to restore hearing and it ranges
from a simple myringoplasty (recon-
struction of the tympanic membrane) to 
more complex ossiculoplasty (recon-
struction of the ossicles).
Unlike mastoidectomy, tympanoplasty
cannot be performed at any age.  It
must be performed at an age when
the conditions are optimal to give the
best results. The recommended age for
tympanoplasty is 10 years and older
because after this age not only does
the incidence of upper respiratory
tract infection decrease but, more
importantly, the Eustachian tube func-
tion improves. 
Complications are commonly associat-
ed with chronic rather than acute otitis
media (see Table IV). They can be
divided into extracranial and intracra-
nial complications.
The most common extracranial compli-
cation is post-auricular subperiosteal
abscess (mastoiditis). Facial palsy is a
rare complication of chronic suppura-
tive otitis media; if present then TB
mastoiditis must be suspected. The
treatment for all extracranial complica-
tions is urgent intravenous antibiotic
therapy, consisting of ampicillin 
60 mg/kg/d, metronidazole 
20 mg/kg/d and mastoidectomy per-
formed as soon as possible, preferably
within 12 hours of presentation.
Intracranial complications must be sus-
pected in all patients who present with
severe headaches, nuchal rigidity or
localising neurological signs with
chronic discharging ears. The investi-
gation of choice is computed tomogra-
phy scan of the brain.   The treatment
for all patients with otogenic intracra-
nial complications is intravenous
antibiotics (ampicillin 60 mg/kg/d,
metronidazole 20 mg/kg/d, and chlo-
ramphenicol 30 mg/kg/d), mastoidec-
tomy and surgical drainage of the
intracranial abscess. The neurosurgical
procedure and mastoidectomy must be
performed under the same anaesthesia
with the neurosurgical procedure
always preceding the mastoidectomy.
Surgery must be undertaken as soon
as possible, not later than 12 hours
after presentation.3
Otogenic intracranial complication is
a serious condition with a mortality of
10 - 30%.
Tuberculous otitis media is a dis-
ease of children — 80% are younger
than 10 years of age. The typical clini-
cal features include painless and pro-
fuse otorrhoea, multiple tympanic
membrane perforations, pale granula-
tions, lower motor neuron facial palsy
(40% incidence), disproportionate
hearing loss, and bone necrosis with
sequestra formation. Evidence of TB in
other sites reinforces the diagnosis,
e.g. pulmonary TB (95%) and pre-
auricular lymphadenopathy (23%).
The diagnosis is confirmed on histol-
ogy of granulation tissue biopsied
either from the middle ear space or
mastoid cavity.4 The treatment is antitu-
berculous therapy for a minimum peri-
od of 6 months.
References available on request.
198  CME April  2004  Vol.22  No.4
EAR INFECT IONS
The tragus, the tortuous S-shape
course of the ear canal and the obliq-
uity of the tympanic membrane offer
protection to the delicate middle ear
structures.
The underlying pathophysiology of
otitis externa is maceration of the skin
of the external ear canal. The hair
and lipid content of cerumen renders
the ear canal impervious to water,
thus preventing infection.
Wax is protective and should not be
removed. It contains lysozyme and
immunoglobulins that inhibit the
growth of bacteria and fungi.
Four types of otitis externa are recog-
nised, non-infective, fungal, bacterial
and diabetic.
Diabetic otitis externa is a life-threat-
ening condition and in order to pre-
vent mortality early diagnosis and
treatment with intravenous triple
antibiotics is mandatory.
The causative organisms in acute oti-
tis media are Haemophilus influenzae
and streptococcus and the treatment
of choice for children living in rural
areas is procaine penicillin and
amoxicillin and for those living in
urban areas either Augmentin or
cefuroxime.
Two types of chronic otitis media are




media is regarded a serious condition
because cholesteatoma releases pro-
teolytic enzymes that cause bone
resorption with extension of infection
into the bony labyrinth, facial canal
and intracranially.
Chronic otitis is regarded as a life-
threatening condition because of its
association with intracranial compli-
cations, which carries a mortality of
10 - 30%.
Tuberculous otitis media is common in
children. The golden rule is that any
child who presents with ipisilateral
otorrhoea and lower motor neuron VII
cranial nerve palsy has tuberculous
otitis media until proven otherwise.
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